Results 151 to 160 of about 576,830 (232)

Prediction of Overall Survival by Thymidine Kinase 1 Combined with Prostate-Specific Antigen in Men with Prostate Cancer. [PDF]

Int J Mol Sci, 2023
Tribukait B, Lundgren PO, Kjellman A, Norming U, Nyman CR, Jagarlmundi K, Gustafsson O.   +6 more
europepmc   +1 more source

Elevated thymidine kinase 1 expression at baseline predicts poor prognosis in breast cancer patients. [PDF]

Front Oncol
Li P, Cheng Y, Zhao J, Fang Y, Zhao T.
europepmc   +1 more source

Serum thymidine kinase 1 concentration as a predictive biomarker in prostate cancer. [PDF]

Prostate, 2022
Lundgren PO, Tribukait B, Kjellman A, Norming U, Jagarlmudi K, Gustafsson O.   +5 more
europepmc   +1 more source

Vitamin D attenuates the progression of pulmonary fibrosis via inhibiting thymidine kinase 1/PFKFB3-driven glycolysis. [PDF]

J Transl Med
Yang H, Zhang L, Han M, Zhu K, Guo X, Yang W, Xu Q.   +6 more
europepmc   +1 more source

Combining circulating inflammatory proteins and thymidine kinase activity to predict survival in melanoma patients receiving immune checkpoint inhibitors. [PDF]

Immunooncol Technol
Egyhazi Brage S, Costa Svedman F, Bergqvist M, Helgadottir H.   +3 more
europepmc   +1 more source

Patients' lived experience of thymidine kinase 2 deficiency: the online survey-based assessment of TK2d patient perspectives study. [PDF]

Ther Adv Rare Dis
Karaa A, Hareendran A, Waller K, Yeske P, Morrison A, Ross M, Balcells C.   +6 more
europepmc   +1 more source

Evaluation of thymidine kinase 1 and folate receptor alpha as potential biomarkers in prostate cancer. [PDF]

Sci Rep
Ahmed SI, Mohy AM, Farid HM, Elnaggar GN.   +3 more
europepmc   +1 more source

Thymidine Kinase 1 Expression Correlates with Tumor Aggressiveness and Metastatic Potential in OSCC. [PDF]

Diagnostics (Basel)
Lee CJ, Peng PW, Wu CY, Chang TM, Liu JF, Lin KC.   +5 more
europepmc   +1 more source

Pyrimidine Nucleos(t)ide Therapy in Patients With Thymidine Kinase 2 Deficiency: A Multicenter Retrospective Chart Review Study. [PDF]

Neurology
Domínguez-González C, Chiang C, Colson AO, Rebollo Mesa I, Baixauli E, Quan J, VanMeter S, Hirano M.   +7 more
europepmc   +1 more source

Prognostic performance of thymidine kinase 1 activity in patients with hormone receptor-positive and HER2-negative metastatic breast cancer treated with CDK4/6 and aromatase inhibitors. [PDF]

Breast Cancer Res Treat
Brown NL, Howell SJ, Papantoniou D, Eriksson O, Bergqvist M, Williams A, Kavanagh A, Backlund A, Albu-Kareem A, Elinder E, Larsson K, Uminska M, Ekholm M.   +12 more
europepmc   +1 more source